Alternate Health Corp.
AHGIF
Other OTC0.00
USD
- -
- -
ISIN
CA02090B1022
CUSIP
02090B102
Return %
Stock
S&P500
1Y
0.00
18.44
3Y
900.00
63.65
5Y
-99.84
74.90
Capital Structure
FRC
•
in mil. unless spec.Working Capital
FRC
•
in mil. unless spec.Growth Rates
FRC
•
in mil. unless spec.Quarterly Revenue
FRC
•
in mil. unless spec.Quarterly Earnings Per Share
FRC
•
in mil. unless spec.Quarterly Dividends Per Share
FRC
•
in mil. unless spec.- CEO
- Howard W. Mann
- Full Time Employees
- 1
- Sector
- Healthcare
- Industry
- Medical - Healthcare Information Services
- Address
- 99 Yorkville Avenue Toronto ON Canada M5R 3K5
- IPO Date
- Jan 27, 2017
- Website
- alternatehealth.com
- Similar Companies
- Business
- Alternate Health Corp. operates as a diversified healthcare company primarily engaged in the hemp-derived cannabidiol (CBD) industry. The company manufactures, packages, and distributes pharmaceutical-grade CBD products across the United States and Canada. Its product portfolio includes topical creams, tinctures, gels for the treatment of pain, scars, and fungal conditions, as well as Hempnesic, a hemp-based pain management cream. Alternate Health provides cloud-based software solutions including medical practice management, controlled substance management software, electronic medical records platforms, blockchain tax collection systems, clinical research services, and continuing education programs primarily serving specialty clinics across North America. Through its subsidiary Blaine Labs, the company is a leader in FDA-registered and cGMP-certified manufacturing and distribution of dermatological and pharmaceutical products with over 50 SKUs available from major retailers such as Walmart, Amazon, CVS, and Walgreens. Founded in 2014 and headquartered in Toronto, Canada, Alternate Health maintains additional offices in Venice, California, and San Antonio, Texas. The company has undergone strategic shifts recently, including exiting the medical laboratory business in 2018 due to changes in US insurance reimbursement policies. In 2019, it acquired Blaine Labs, expanding its footprint into medical product manufacturing and broadening its product offerings. More recently, Alternate Health has advanced large-scale clinical studies on cannabis/CBD applications, and continues to invest in the development and distribution of hemp-based products and healthcare software platforms. The company leverages technology and data analytics to support patient care and research, reinforcing its position as a technology-driven health service provider in the CBD sector. Alternate Health's operations span product manufacturing, software services, medical practice management, and clinical research with a focus on the North American market. It is listed on the Canadian Securities Exchange (ticker AHG) and OTCQB (ticker AHGIF) in the US. The company’s integrated approach combining pharmaceutical product development with healthcare software solutions differentiates it within the growing CBD healthcare market, supported by recent funding rounds, partnerships, and an emphasis on regulatory compliance and quality standards.
Alternate Health (OTCMKTS:AHGIF) & Tempus AI (NASDAQ:TEM) Head-To-Head Review
Pulmonx (NASDAQ:LUNG) & Alternate Health (OTCMKTS:AHGIF) Critical Comparison